Associated Papers
Melatonin receptor 1A variants as genetic cause of idiopathic osteoporosis.
Bisikirska B et al.
Science Translational Medicine, 2024
Identification of novel genes by targeted exome sequencing in Retinoblastoma.
Bisht S et al.
Ophthalmic Genetics, 2022
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy.
D'Agostino Y et al.
Diagnostics (basel, Switzerland), 2022
BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
Roohollahi K et al.
Scientific Reports, 2022
Common germline-somatic variant interactions in advanced urothelial cancer.
Vosoughi A et al.
Nature Communications, 2020
ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling.
Arya SB et al.
The Journal of Biological Chemistry, 2018
Next-generation sequencing in familial breast cancer patients from Lebanon.
Jalkh N et al.
Bmc Medical Genomics, 2017
ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Hamadou WS et al.
Bulletin Du Cancer, 2017
ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.
Jiang Y et al.
Hereditary Cancer in Clinical Practice, 2017
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I et al.
Human Genomics, 2015
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway.
Di Fruscio G et al.
Autophagy, 2015
T Allele of nonsense polymorphism (rs2039381, Gln71Stop) of interferon-ε is a risk factor for the development of intracerebral hemorrhage.
Kim SK et al.
Human Immunology, 2014
ARLTS1 and prostate cancer risk--analysis of expression and regulation.
Siltanen S et al.
Plos One, 2013
ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.
Akisik E et al.
Molecular Biology Reports, 2011
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
Siltanen S et al.
Plos One, 2011
Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK et al.
Clinical Genetics, 2010
Association of the ARLTS1 variants with familial ovarian cancer risk in China.
Yang XY et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2009
Inherited predisposition to chronic lymphocytic leukemia.
Brown JR
Expert Review of Hematology, 2008
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S et al.
European Journal of Human Genetics : Ejhg, 2008
Tumor suppressor functions of ARLTS1 in lung cancers.
Yendamuri S et al.
Cancer Research, 2007
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.
Castellví-Bel S et al.
Carcinogenesis, 2007
ARLTS1 Trp149Stop mutation and the risk of ovarian cancer.
Masojc B et al.
Cancer Research, 2007
No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia.
Ng D et al.
British Journal of Haematology, 2007
ARLTS1 polymorphisms and basal cell carcinoma of the skin.
Li X et al.
Hereditary Cancer in Clinical Practice, 2007
Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia.
Sellick GS et al.
Leukemia Research, 2006
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.
Petrocca F et al.
Cancer Research, 2006
ARLTS1 variants and melanoma risk.
Frank B et al.
International Journal of Cancer, 2006
Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene.
Masojć B et al.
Breast Cancer Research and Treatment, 2006
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.
Corral J et al.
Blood, 2006
Familial pancreatic cancer syndromes.
Habbe N et al.
Endocrinology and Metabolism Clinics of North America, 2006
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
Frank B et al.
International Journal of Cancer, 2006
Familial cancer associated with a polymorphism in ARLTS1.
Sellick GS et al.
The New England Journal of Medicine, 2006
Familial cancer and ARLTS1.
De Brakeleer S et al.
The New England Journal of Medicine, 2005
Familial cancer associated with a polymorphism in ARLTS1.
Calin GA et al.
The New England Journal of Medicine, 2005